Search results
26 maj 2017 · The term ‘economy class syndrome’ refers to the occurrence of thrombotic events during long-haul flights that mainly occur in passengers in the economy class of the aircraft. This syndrome results from several factors related to the aircraft cabin (immobilization, hypobaric hypoxia and low humidity) and the passenger (body mass index ...
1 sie 2021 · Economy class syndrome refers to the occurrence of thrombotic events during long-haul flights, mainly in economy class passengers. The clinical condition defined here is observed not only in those travelling in economy class, but also in those travelling by land according to the studies.
The term 'economy class syndrome' refers to the occurrence of thrombotic events during long-haul flights that mainly occur in passengers in the economy class of the aircraft. This syndrome results from several factors related to the aircraft cabin (immobilization, hypobaric hypoxia and low humidity) ….
6 sty 2023 · Venous thromboembolism (VTE) includes deep venous thrombosis (DVT) and pulmonary embolism, when it happens during long-haul flights, it is also called “economy class syndrome.” The first economy class syndrome was reported in the early 1950s.
Causes of economy class syndrome. Lack of adequate fluids, and dehydration caused by drinking alcohol which induces diuresis (an increase in urination), contribute to an increase in blood viscosity. Learn more about causes of traveller's thrombosis.
The term economy class syndrome’ was first used in an article in 1988 by Cruick-shank (Cruickshank, Gorlin & Jennet, 1988) to describe three cases of thrombosis after long-haul air flights. This term may not be strictly accurate as the risk of thrombosis may also be increased when taking any long journey.
17 lip 2014 · Those who do develop DVT should be treated using anticoagulant and possibly thrombolytic therapy. This article discusses the factors that increase a patient’s risk of developing DVT in flight, possible prophylactic measures that can be taken, and therapeutic strategies that are currently available in the U.S. market.
